Literature DB >> 9029089

Regulation of CD28 costimulation in human CD8+ T cells.

T E Lloyd1, L Yang, D N Tang, T Bennett, W Schober, D E Lewis.   

Abstract

Optimal stimulation and prevention of anergy in T cells requires signaling through the CD28 molecule. During HIV disease progression, CD28 expression is lost, particularly on CD8+ T cells. Because alterations in cytokine production patterns occur during HIV infection, we determined whether CD8+ T cell phenotype or function was affected by cytokine environment. Treatment of CD8+ T cells with IL-4 decreased levels of both CD28 surface expression and message and increased CD8 expression. Furthermore, CD8+ T cells that had down-regulated CD28 had reduced proliferative capacity. The inhibitory effects of CD28 reduction could be compensated either by increased anti-CD3 or by exogenous IL-2, suggesting that the strength of T cell signaling necessary for the production of IL-2 and subsequent proliferation is negatively regulated by IL-4. CD8+ subpopulations with differential CD28 expression produced different patterns of cytokines, particularly IL-2 and IFN-gamma. Furthermore, CD8+ T cells that had reduced CD28 levels but made their own IL-2 were able to proliferate in response to TCR stimulation. These results suggest that loss of CD28 expression and CD8 T cell function can be regulated by the cytokine environment, which may be altered during HIV disease progression. Whether the dysfunction of CD8+ T cells in HIV infection occurs by such a mechanism is the subject of future investigation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029089

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

Authors:  G M Gillespie; M R Wills; V Appay; C O'Callaghan; M Murphy; N Smith; P Sissons; S Rowland-Jones; J I Bell; P A Moss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.

Authors:  R S Veazey; I C Tham; K G Mansfield; M DeMaria; A E Forand; D E Shvetz; L V Chalifoux; P K Sehgal; A A Lackner
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Progressive decrease of CD8high+ CD28+ CD57- cells with ageing.

Authors:  J Merino; M A Martínez-González; M Rubio; S Inogés; A Sánchez-Ibarrola; M L Subirá
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

4.  Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation.

Authors:  L A Trimble; P Shankar; M Patterson; J P Daily; J Lieberman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life.

Authors:  Nazma Mansoor; Brian Abel; Thomas J Scriba; Jane Hughes; Marwou de Kock; Michele Tameris; Sylvia Mlenjeni; Lea Denation; Francesca Little; Sebastian Gelderbloem; Anthony Hawkridge; W Henry Boom; Gilla Kaplan; Gregory D Hussey; Willem A Hanekom
Journal:  Clin Immunol       Date:  2008-11-08       Impact factor: 3.969

6.  Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis.

Authors:  James A DeVoti; Bettie M Steinberg; David W Rosenthal; Lynda Hatam; Andrea Vambutas; Allan L Abramson; Mark J Shikowitz; Vincent R Bonagura
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

7.  Expansion of a CD28-intermediate subset among CD8 T cells in patients with infectious mononucleosis.

Authors:  Hiroshi Uda; Toru Mima; Norihiko Yamaguchi; Yoshinori Katada; Masayuki Fukuda; Naohiko Fujii; Kojiro Nakamura; Osamu Saiki
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection.

Authors:  Nesrina Imami; Antonio Pires; Gareth Hardy; Jamie Wilson; Brian Gazzard; Frances Gotch
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections.

Authors:  David A Kosub; Ginger Lehrman; Jeffrey M Milush; Dejiang Zhou; Elizabeth Chacko; Amanda Leone; Shari Gordon; Guido Silvestri; James G Else; Philip Keiser; Mamta K Jain; Donald L Sodora
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

10.  Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease.

Authors:  Habib Houman; Agnes Hamzaoui; Imed Ben Ghorbal; Monia Smiti Khanfir; Moncef Feki; Kamel Hamzaoui
Journal:  Mediators Inflamm       Date:  2004-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.